# Crcle Guaifenesin Extended-Release Tablets, 600 mg

NDC: 57483-270
Generic name: Guaifenesin Extended-Release
Labeler / Manufacturer: Innovus Pharmaceuticals, Inc.
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20200910

FDA application: ANDA213420

## Active ingredients

- GUAIFENESIN: 600 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"57483-270"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=57483-270
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bba4b91a-bea9-41be-9588-5fb1483c7d10